Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)
CNY 15.72
(-1.63%)
CNY 15.72
(-1.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -72.13 Million | 50.43 Million | 7.41 Million | 93.72 Million | 107.52 Million | 62.63 Million |
| Net Income | -50.77 Million | -76.78 Million | 32.99 Million | 36.45 Million | 46.06 Million | 57.76 Million |
| Depreciation & Amortization | 37.71 Million | 25.34 Million | 16.37 Million | 11.95 Million | 11.9 Million | 10.75 Million |
| Deferred income taxes | -12.75 Million | -8.97 Million | -1.66 Million | -469.91 Thousand | -107.13 Thousand | -153.03 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -131.99 Million | 1.87 Million | -36.61 Million | 41.07 Million | 55.85 Million | 2.72 Million |
| Other non-cash items | 24.47 Million | 100 Million | -5.33 Million | 4.23 Million | -6.3 Million | -8.6 Million |
| Investing Cash Flow | -45.96 Million | -43.39 Million | -378.97 Million | -197.85 Million | -63.23 Million | -47.7 Million |
| Investments in PPE | -72.38 Million | -138.13 Million | -290.3 Million | -262.88 Million | -81.44 Million | -5.58 Million |
| Acquisitions | 982 Thousand | 141.57 Thousand | -8.26 Million | -32.54 Million | 39.78 Thousand | -10.92 Million |
| Investment purchases | -78.7 Million | -307.28 Million | -476.9 Million | -348.12 Million | -602.45 Million | -1.05 Billion |
| Sales/Maturities of investments | 78.47 Million | 399.37 Million | 396.71 Million | 447.45 Million | 618.52 Million | 1.02 Billion |
| Other Investing Activities | 25.34 Million | 2.49 Million | -223.32 Thousand | -1.75 Million | 2.1 Million | 4.16 Million |
| Financing Cash Flow | 54.64 Million | 7.59 Million | 378.3 Million | 23.33 Million | 1.22 Million | -27.66 Million |
| Debt repayment | -94.13 Million | -169.35 Million | -62.55 Million | -16.88 Million | -7.85 Million | -5.1 Million |
| Dividends payments | -30.73 Million | -7.39 Million | -6.99 Million | -8.58 Million | -11.28 Million | -21.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.55 Million | 209.2 Million | 474.24 Million | 50.19 Million | 20.81 Million | -1.38 Million |
| Accounts receivables | -82.39 Million | -26.83 Million | 1.25 Million | 33.23 Million | 75.36 Million | 32.05 Million |
| Accounts payables | -65.29 Million | 44.77 Million | -26.98 Million | 8.43 Million | -17.18 Million | -10.11 Million |
| Inventory | 28.44 Million | -7.08 Million | -9.21 Million | -127.54 Thousand | -2.21 Million | -19.06 Million |
| Other working capital | -4.81 Million | -8.97 Million | -1.66 Million | -469.91 Thousand | -107.13 Thousand | 21.78 Million |
| Cash at beginning of period | 206.27 Million | 191.64 Million | 184.9 Million | 265.7 Million | 220.18 Million | 232.91 Million |
| Cash at end of period | 142.81 Million | 206.27 Million | 191.64 Million | 184.9 Million | 265.7 Million | 220.18 Million |
| Capital Expenditure | -72.38 Million | -138.13 Million | -290.3 Million | -262.88 Million | -81.44 Million | -5.58 Million |
| Effect of forex changes on cash | - | - | -0.55 | 1.23 | - | - |
| Net cash flow / Change in cash | -63.45 Million | 14.62 Million | 6.74 Million | -80.8 Million | 45.51 Million | -12.72 Million |
| Free Cash Flow | -144.51 Million | -87.69 Million | -282.88 Million | -169.16 Million | 26.07 Million | 57.05 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -29.58 Million | -9.78 Million | 1.08 Million | -35.38 Million | -50.77 Million | -3.37 Million |
| Depreciation & Amortization | - | 15.42 Million | 15.42 Million | 37.71 Million | 37.71 Million | -16.1 Million |
| Deferred income taxes | - | - | - | - | -12.75 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -32.2 Million | - | -58.76 Million | -131.99 Million | 56.08 Million |
| Other non-cash items | 8.84 Million | 3.14 Million | 7.43 Million | 83.52 Million | 24.47 Million | -55.98 Million |
| Investing Cash Flow | -65.01 Million | -9.41 Million | 10.7 Million | -13.14 Million | -45.96 Million | -14.38 Million |
| Investments in PPE | -19.45 Million | -14.45 Million | -10.16 Million | -13.23 Million | -72.38 Million | -16.49 Million |
| Acquisitions | 902.76 Thousand | 2.63 Million | 369.9 Thousand | 26.32 Million | 982 Thousand | -25.26 Million |
| Investment purchases | -15.98 Million | -20 Million | - | -56.32 Million | -78.7 Million | 23.15 Million |
| Sales/Maturities of investments | - | 20.36 Million | 20 Million | 55.42 Million | 78.47 Million | 2.11 Million |
| Other Investing Activities | -30.47 Million | 2.04 Million | 504.51 Thousand | 0.01 | 25.34 Million | 2.11 Million |
| Financing Cash Flow | 20.41 Million | 109.96 Million | -68.78 Million | -73.75 Million | 54.64 Million | 2.47 Million |
| Debt repayment | -7.97 Million | -115.66 Million | -63.17 Million | -62.55 Million | -94.13 Million | -22.79 Million |
| Dividends payments | - | -6.1 Million | -6 Million | -5.57 Million | -30.73 Million | -5.66 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 12.44 Million | -5.7 Million | -5.6 Million | -4.33 Million | -5.55 Million | 30.93 Million |
| Accounts receivables | - | -7.5 Million | - | -82.39 Million | -82.39 Million | 28.63 Million |
| Accounts payables | - | - | - | - | -65.29 Million | - |
| Inventory | - | -24.7 Million | - | 28.44 Million | 28.44 Million | 27.44 Million |
| Other working capital | - | - | - | -4.81 Million | -4.81 Million | - |
| Cash at beginning of period | 173.36 Million | 94.19 Million | 222.62 Million | 202.62 Million | 206.27 Million | 233.95 Million |
| Cash at end of period | 125.05 Million | 173.36 Million | 94.19 Million | 142.81 Million | 142.81 Million | 202.62 Million |
| Capital Expenditure | -19.45 Million | -14.45 Million | -10.16 Million | -13.23 Million | -72.38 Million | -16.49 Million |
| Effect of forex changes on cash | - | - | - | - | - | -35.29 Thousand |
| Net cash flow / Change in cash | -48.31 Million | 79.17 Million | -128.42 Million | -59.8 Million | -63.45 Million | -31.33 Million |
| Free Cash Flow | -40.19 Million | -36.52 Million | -1.64 Million | 13.85 Million | -144.51 Million | -35.87 Million |
PLUS
SOMATEX
ALHIT
8881
BHR-PB
MLRZE